Arrowhead Pharmaceuticals Aktie
53,54
EUR
-0,22
EUR
-0,41
%
63,41
USD
-0,27
USD
-0,42
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
| 07.09.18 | Arrowhead Pharmaceuticals Buy | B. Riley FBR | |
| 06.09.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
| 08.08.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 02.07.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
| 09.05.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 10.11.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
| 19.05.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets |
Werbung
Werbung